Researchers at Ann Arbor-based Michigan Medicine’s Rogel Cancer Center and Stanford (Calif.) University will extend genetic testing to at-risk relatives of cancer patients with hereditary mutations.
The services will be provided through a $3.2 million grant from the National Cancer Institute, according to a June 29 news release from Michigan Medicine.
Researchers will use the Surveillance, Epidemiology and End Results program data to reach nearly 4,000 adult cancer survivors who carry genetic mutations associated with cancer-risk. Once enrolled, patients will invite first- and second-degree relatives to receive online education and at-home genetic testing.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
